Whether it is rich or poor, once they get cancer, they will do their best to hand over their life savings to Oracle Pharmaceutical.

If this medicine is regarded as a strategic material, it can not only make money from other countries, but can even use it as a bargaining chip to force the other party to make more concessions. Therefore, the first thought of any government about such a good thing will be that they must get it!

Seeing Charlie’s dissatisfaction, James Smith choked and said, “Mr. Wade, this matter you are talking about is beyond my control.

After all, I am only the person in charge of the FDA, who is responsible for the approval and supervision of drugs.

As for other departments I really have no ability to interfere…”

After speaking, he looked at Charlie and begged bitterly, “Mr. Wade, now I just ask you to see that I have a child with cancer.

As his father, sell me some Healing Salve Pills so that my son can survive…”

Charlie smiled lightly and said, “I’m sorry, I didn’t tell you something.

after the careful decision of Oracle Pharmaceutical, the Healing

it clearly, it is giving up all

Salve Pill, which Charlie specially created to stimulate the FDA. At that time, the FDA was very hostile to patent

be marketed in the United States. Because throughout Europe and the United

countries in Europe and the United States will open their doors to this

countries will have many times stricter review processes for it, and

introduced Healing Salve Pill, which was regarded by the FDA

Healing Salve Pill itself is not a drug that

Healing

Oracle Pharmaceutical is providing free intensive treatment for terminal cancer patients with family difficulties in China, I beg you, can you give my son a quota, my little Jimmy is so pitiful,

“You said it yourself, Oracle Pharmaceutical’s free medical treatment is

condition is

and your son do

at Chinese patients, and there are countless Chinese patients who can’t wait for this

The Novel will be updated daily. Come back and continue reading tomorrow, everyone!

Comments ()

0/255